Sharan Raghow

572 total citations
10 papers, 449 citations indexed

About

Sharan Raghow is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sharan Raghow has authored 10 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Genetics and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sharan Raghow's work include Prostate Cancer Treatment and Research (7 papers), Estrogen and related hormone effects (5 papers) and Hormonal and reproductive studies (4 papers). Sharan Raghow is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Estrogen and related hormone effects (5 papers) and Hormonal and reproductive studies (4 papers). Sharan Raghow collaborates with scholars based in United States. Sharan Raghow's co-authors include Mitchell S. Steiner, Sanjay Katiyar, James T. Dalton, Karen A. Veverka, Emin Kuliyev, Jeetendra Eswaraka, Ramesh Narayanan, Christina M. Barrett, Norman M. Greenberg and Muralimohan Yepuru and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Urology and Urology.

In The Last Decade

Sharan Raghow

10 papers receiving 422 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharan Raghow United States 8 205 203 120 94 85 10 449
Saija Salmi Finland 5 342 1.7× 176 0.9× 209 1.7× 136 1.4× 56 0.7× 6 588
A. Stuart Wright Canada 7 61 0.3× 216 1.1× 212 1.8× 111 1.2× 29 0.3× 9 380
Caroline Coletti United States 11 35 0.2× 116 0.6× 73 0.6× 150 1.6× 25 0.3× 12 412
Maurice E. Fabiani Australia 8 31 0.2× 60 0.3× 172 1.4× 109 1.2× 17 0.2× 8 402
Michele Salerno Italy 12 193 0.9× 24 0.1× 206 1.7× 247 2.6× 54 0.6× 17 467
Issa M. Shamonki United States 7 179 0.9× 22 0.1× 184 1.5× 125 1.3× 15 0.2× 7 468
Yibo Zhuang China 10 47 0.2× 45 0.2× 36 0.3× 232 2.5× 23 0.3× 15 396
Min Shi China 11 59 0.3× 103 0.5× 137 1.1× 126 1.3× 25 0.3× 24 473
Ka Wah Li United Kingdom 9 149 0.7× 59 0.3× 95 0.8× 121 1.3× 55 0.6× 11 511
Marta Camilot Italy 12 80 0.4× 29 0.1× 157 1.3× 157 1.7× 20 0.2× 29 385

Countries citing papers authored by Sharan Raghow

Since Specialization
Citations

This map shows the geographic impact of Sharan Raghow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharan Raghow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharan Raghow more than expected).

Fields of papers citing papers by Sharan Raghow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharan Raghow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharan Raghow. The network helps show where Sharan Raghow may publish in the future.

Co-authorship network of co-authors of Sharan Raghow

This figure shows the co-authorship network connecting the top 25 collaborators of Sharan Raghow. A scholar is included among the top collaborators of Sharan Raghow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharan Raghow. Sharan Raghow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Yepuru, Muralimohan, Jeetendra Eswaraka, Jeffrey D. Kearbey, et al.. (2010). Estrogen Receptor-β-selective Ligands Alleviate High-fat Diet- and Ovariectomy-induced Obesity in Mice. Journal of Biological Chemistry. 285(41). 31292–31303. 101 indexed citations
2.
Taneja, Samir S., Matthew R. Smith, James T. Dalton, et al.. (2006). Toremifene – a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy. Expert Opinion on Investigational Drugs. 15(3). 293–305. 20 indexed citations
3.
Steiner, Mitchell S. & Sharan Raghow. (2003). Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk. World Journal of Urology. 21(1). 31–36. 58 indexed citations
4.
Raghow, Sharan, et al.. (2002). Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.. PubMed. 62(5). 1370–6. 125 indexed citations
5.
Steiner, Mitchell S., et al.. (2001). Selective estrogen receptor modulators for the chemoprevention of prostate cancer. Urology. 57(4). 68–72. 36 indexed citations
6.
Raghow, Sharan, et al.. (2000). Efficacious chemoprevention of primary prostate cancer by flutamide in an autochthonous transgenic model.. PubMed. 60(15). 4093–7. 50 indexed citations
7.
Steiner, Mitchell S., et al.. (1999). THE CHIMPANZEE AS A MODEL OF HUMAN BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 1454–1461. 2 indexed citations
8.
Raghow, Sharan, Emin Kuliyev, Mitchell S. Steiner, & Norman M. Greenberg. (1999). FLUTAMIDE FOR CHEMOPREVENTION OF PROSTATE CANCER. The Journal of Urology. 70–70. 5 indexed citations
9.
Steiner, Mitchell S., et al.. (1999). THE CHIMPANZEE AS A MODEL OF HUMAN BENIGN PROSTATIC HYPERPLASIA. The Journal of Urology. 162(4). 1454–1461. 42 indexed citations
10.
Raghow, Sharan, Ellen Shapiro, & Mitchell S. Steiner. (1999). IMMUNOHISTOCHEMICAL LOCALIZATION OF TRANSFORMING GROWTH FACTOR-alpha AND TRANSFORMING GROWTH FACTOR-beta DURING EARLY HUMAN FETAL PROSTATE DEVELOPMENT. The Journal of Urology. 162(2). 509–513. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saija Salmi Breakdown of academic impact, for papers by A. Stuart Wright Breakdown of academic impact, for papers by Caroline Coletti Breakdown of academic impact, for papers by Maurice E. Fabiani Breakdown of academic impact, for papers by Michele Salerno Breakdown of academic impact, for papers by Issa M. Shamonki Breakdown of academic impact, for papers by Yibo Zhuang Breakdown of academic impact, for papers by Min Shi Breakdown of academic impact, for papers by Ka Wah Li Breakdown of academic impact, for papers by Marta Camilot
Rankless by CCL
2026